Transcriptional regulation of B-cell differentiation

Current Opinion in Immunology

Volumn 10, Issue 2, 1998, Pages 158-165

  Reya, Tannishtha ^a   Rudolf, Grosschedl ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR;

B LYMPHOCYTE DIFFERENTIATION; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; NONHUMAN; REVIEW; TRANSCRIPTION REGULATION;

EID: 0344734109     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0952-7915(98)80244-6     Document Type: Article

References (64)

1. Hardy RR, Carmack CE, Shinton SA, Kemp JD, Hayakawa K. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med. 173:1991;1213-1225.
2. Rolink A, Melchers F. B lymphopoiesis in the mouse. Adv Immunol. 53:1993;123-156.
3. Li YS, Wasserman R, Hayakawa K, Hardy RR. Identification of the earliest B lineage stage in mouse bone marrow. Immunity. 5:1996;527-535.
4. Hromas R, Orazi A, Neiman R, Maki R, Van Beveran C, Moore J, Klemsz M. Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood. 82:1993;2998-3004.
5. Scott EW, Simon MC, Anastasi J, Singh H. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science. 265:1994;1573-1577.
6. Olson MC, Scott EW, Hack AA, Su GH, Tenen DG, Singh H, Simon MC. PU.1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity. 3:1995;703-714.
7. of outstanding interest Scott EW, Fisher RC, Olson MC, Kehrli EW, Simon MC, Singh H. Pu.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity. 6:1997;437-447 This paper provides valuable insight into the defects in the PU.1-deficent mice. It demonstrates the cell-autonomous nature of the requirement for PU.1 and defines defects in the stem cell compartment that suggest that the loss of myeloid and B cells in these mice is due to a problem with a putative common progenitor.
8. McKercher S, Torbett B, Anderson K, Henkel GW, Vestal DJ, Baribault H, Klemsz M, Feeney AJ, Wu GE, Paige CJ, Maki RA. Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities. EMBO J. 15:1996;5647-5658.
9. Eisenbeis CF, Singh H, Storb U. Pip, a novel IRF family member, is a lymphoid-specific PU.1-dependent transcriptional activator. Genes Dev. 9:1995;1377-1387.
10. Pongubala JMR, Atchison ML. PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Biochemistry. 94:1997;127-132.
11. Brass AL, Kehrli E, Eisenbeis CF, Storb U, Singh H. Pip, a lymphoid-restricted IRF, contains a regulatory domain that is important for autoinhibition and ternary complex formation with the Ets factor PU.1. Genes Dev. 10:1996;2335-2347.
12. Yamagata T, Nishida J, Tanaka T, Sakai R, Mitani K, Yoshida M, Taniguchi T, Yazaki Y, Hirai H. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon regulated genes. Mol Cell Biol. 16:1996;1283-1294.
13. Mittrucker H-W, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A, Wakeham A, Patterson B, Ohashi PS, Mak TW. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science. 275:1997;540-543.
14. Georgopoulos K, Winandy S, Avitahl N. The role of the Ikaros gene in lymphocyte development and homeostasis. Annu Rev Immunol. 15:1997;155-176.
15. of outstanding interest Hahm K, Cobb BS, McCarty AS, Brown KE, Klug CA, Lee R, Akashi K, Weissman I, Fisher AG, Smale ST. Helios, a T cell-restricted Ikaros family member that quantitatively associates with Ikaros at centromeric heterochromatin. Genes Dev. 12:1998;782-796 This paper describes a novel member of the Ikaros family, Helios. Its specific expression on T cells provides a basis for postulating that the severe defects observed in the dominant-negative ikaros mutation may be due to blocking Helios' function. The paper also describes Helios' function as a repressor.
16. Klug CA, Morrison SJ, Masek M, Hahm K, Smale ST, Weissman IL. Hematopoietic stem cells and lymphoid progenitors express different Ikaros isoforms, and Ikaros is localized to heterochromatin in immature lymphocytes. Proc Natl Acad Sci USA. 95:1998;657-662.
17. Morgan B, Sun L, Avitahl N, Andrikopoulos K, Ikeda T, Gonzales E, Wu P, Neben S, Georgopoulos K. Aiolos, a lymphoid restricted transcription factor that interacts with Ikaros to regulate lymphocyte differentiation. EMBO J. 16:1997;2004-2013.
18. Lo K, Landau NR, Smale ST. LyF-1, a transcriptional regulator that interacts with a novel class of promoters for lymphocyte-specific genes. Mol Cell Biol. 11:1991;5229-5243.
19. Sun L, Liu A, Georgopoulos K. Zinc finger-mediated protein interactions modulate Ikaros activity, a molecular control of lymphocyte development. EMBO J. 15:1996;5358-5369.
20. of outstanding interest Wang J-H, Nichogiannopoulou A, Wu L, Sun L, Sharpe AH, Bigby M, Georgopoulos K. Selective defects in the development of the fetal, adult lymphoid system in mice with an Ikaros null mutation. Immunity. 6:1996;537-549 This paper describes the phenotype due to a null mutation of Ikaros (generated by disrupting the carboxyl terminus dimerization domain) and highlights the differences between this and the dominant negative mutation of Ikaros. It also provides interesting evidence for a very marked differential requirement for Ikaros between T cell development in the fetus and adult.
21. Georgopoulos K, Bigby M, Wang J-H, Molnar A, Wu P, Winandy S, Sharpe A. The Ikaros gene is required for the development of all lymphoid lineages. Cell. 79:1994;143-156.
22. of outstanding interest Brown KE, Guest SS, Smale ST, Hahm K, Merkenschlager M, Fisher AG. Association of transcriptionally silent genes with Ikaros complexes at centromeric heterochromatin. Cell. 91:1997;845-854 This paper is the first to describe the localization of the Ikaros gene within the nucleus and reports that Ikaros is associated with heterochromatin and transcriptionally silent loci. These findings suggest that these proteins may be involved in repression of gene expression.
23. Verma IM, Stevenson JK, Schwarz EM, van Antwerp D, Miyamoto S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev. 9:1995;2723-2735.
24. Baldwin AS. The NF-kappa B, I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 14:1996;649-683.
25. Doi TS, Takahashi T, Taguchi O, Azuma T, Obata Y. NF-κB RelA-deficient lymphocytes: normal development of T cells and B cells, impaired production of IgA and IgG1 and reduced proliferative responses. J Exp Med. 185:1997;953-961.
26. + cells, while mice lacking either one alone have relatively normal B-cell development. This paper is additionally interesting because it suggests that the loss of secreted, or cell bound signals from wild-type hematopoietic cells may be the basis for this defect.
27. Sha WC, Liou H-C, Tuomanen EI, Baltimore D. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune response. Cell. 80:1995;321-330.
28. Snapper CM, Zelazowski P, Rosas FR, Kehry MR, Tian M, Baltimore D, Sha WR. B cells from p50/NF-κB knockout mice have selective defects in proliferation, differentiation, germ line CH transcription, and Ig class switching. J Immunol. 156:1996;183-191.
29. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck R-P, Lira SA, Bravo R. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell. 80:1995;331-340.
30. Snapper CM, Rosas FR, Zelazowski P, Moorman MA, Kehry MR, Bravo R, Weih F. B cells lacking relB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J Exp Med. 184:1996;1537-1541.
31. Weih F, Durham SK, Barton DS, Sha WC, Baltimore D, Bravo R. Both multiorgan inflammation and myeloid hyperplasia in relB-deficient mice are T cell dependent. J Immunol. 157:1996;3974-3979.
32. null double-knockout mice. J Exp Med. 185:1997;1359-1370.
33. + cells in the periphery.
34. Kadesch T. Helix-loop-helix proteins in the regulation of the immunoglobulin gene transcription. Immunol Today. 13:1992;31-36.
35. Shen CP, Kadesch T. B cell specific DNA binding by an E47 homodimer. Mol Cell Biol. 15:1995;4518-4524.
36. Staudt LM, Lenardo MJ. Immunoglobulin gene transcription. Annu Res Immunol. 9:1991;373-398.
37. Schlissel MS, Voronova A, Baltimore D. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre T-cell line. Genes Dev. 5:1991;1367-1376.
38. Choi JK, Shen CP, Radomska HS, Eckhardt LA, Kadesch T. E47 activates the Ig-heavy chain and TdT loci in non-B cells. EMBO J. 15:1996;5014-5021*.
39. Bain G, Robanus Maandag EC, Izon DJ, Amsen D, Kruisbeek AM, Weintraub BC, Krop I, Schlissel MS, Feeney AJ, van Roon M, et al. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell. 79:1994;885-892.
40. Zhuang Y, Soriano P, Weintraub H. The helix-loop-helix gene E2A is required for B cell formation. Cell. 79:1994;875-884.
41. Bain G, Robanus Maandag EC, te Riele HPJ, Feeney AJ, Sheehy A, Schlissel MS, Shinton SA, Hardy RR, Murre C. Both E12 and E47 allow commitment to the B cell lineage. Immunity. 6:1997;145-154.
42. of special interest Eckner R, Yao TP, Oldread E, Livingston DM. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle, B-cell differentiation. Genes Dev. 10:1996;2478-2490.
43. Zhuang Y, Cheng P, Weintraub H. B-Lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol Cell Biol. 16:1996;2898-2905 Using double-heterozygous mice, this paper demonstrates the functional redundancy between three members of the basic helix-loop-helix family of transcription factors.
44. Roberts VJ, Steenbergen R, Murre C. Localization of E2A-mRNA expression in developing and adult rat tissues. Proc Natl Acad Sci USA. 90:1993;7583-7587.
45. Goldfarb AN, Flores JP, Lewandowska K. Involvement of the E2A basic helix-loop-helix protein immunoglobulin heavy chain class switching. Mol Immunol. 33:1996;947-956.
46. Hagman J, Travis A, Grosschedl R. A novel lineage-specific nuclear factor regulates mb-1 gene transcription of the early stages of B cell differentiation. EMBO J. 10:1991;3409-3417.
47. Lin H, Grosschedl R. Failure of B-cell differentiation in mice lacking the transcription factor EBF. Nature. 376:1995;263-267.
48. null mice.
49. Busslinger M, Urbânek P. The role of BSAP (Pax-5) in B-cell development. Curr Opin Genet Dev. 5:1995;595-601.
50. Zwollo P, Arrieta H, Ede K, Molinder K, Desiderio S, Pollock R. The Pax-5 gene is alternatively spliced during B-cell development. J Biol Chem. 272:1997;10160-10168.
51. Urbanek P, Wang Z-Q, Fetka I, Wagner EF, Busslinger M. Complete block of early B cell differentiation and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell. 79:1994;901-912.
52. null mice. It reveals a marked difference in the requirement for Pax-5 between fetal liver, and adult, B cell development. It is made even more interesting by the finding that the more severe defect that occurs in fetal B cells is due to an influence of the fetal microenvironment.
53. Wakatsuki Y, Neurath MF, Max EE, Strober W. The B cell-specific transcription factor BSAP regulates B cell proliferation. J Exp Med. 179:1994;10099-10108.
54. Usui T, Wakatsuki Y, Matsunaga Y, Kaneko S, Kosek H, Kita T. Overexpression of B cell-specific activator protein (BSAP/Pax-5) in a late B cell is sufficient suppress differentiation to an Ig high producer cell with plasma cell phenotype. J Immunol. 158:1997;3197-3204.
55. Corcoran LM, Karvelas M, Nossal GJV, Ye Z-S, Jacks T, Baltimore D. Oct-2, although not required for early B-cell development, is critical for later B-cell maturation and for postnatal survival. Genes Dev. 7:1993;570-582.
56. Luo Y, Roeder R. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol Cell Biol. 15:1995;4115-4124.
57. Strubin M, Newell JW, Matthias P. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell. 80:1995;497-506.
58. Gstaiger M, Georgiev O, van Leeuwen H, van der Vliet P, Schaffner W. The B cell coactivator Bob 1 shows DNA sequence dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation. EMBO J. 15:1996;2781-2790.
59. of special interest Schubart DB, Rolink A, Kosco-Vilbois MH, Botteri F, Matthias P. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature. 383:1996;538-542 This paper reports that inactivation of the Oca-B gene allows normal B cell development, but results in severe problems in peripheral B cell function.
60. Turner CA, Mack DH, Davis MM. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell. 77:1994;297-306.
61. Lin Y, Wong K-K, Calame K. Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation. Science. 276:1997;596-599.
62. Baeuerle PA. Proinflammatory signalling: last pieces in the NF-κB puzzle? Curr Biol. 8:1998;R19-R22.
63. DeFranco AL. The complexity of signaling pathways activated by the BCR. Curr Opin Immunol. 9:1997;296-308.
64. Corcoran AE, Smart FM, Cowling RJ, Crompton T, Owen MJ, Venkitaraman AR. The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J. 15:1996;1924-1932.